For months, Health and Human Services Secretary Robert F. Kennedy Jr. has warned that America is facing an autism crisis like never before. Earlier this year, he sounded the alarm at a press conference, pointing to numbers that should shock every parent in the country: autism rates in 8-year-olds have climbed to 1 in 31, with American boys facing a staggering 1 in 20 chance of diagnosis. In California, the figure is even worse—1 in 12.5. Kennedy promised President Donald Trump that his department would get to the bottom of it, vowing that by September, “we will know what has caused the autism epidemic and we’ll be able to eliminate those exposures.”

Now, a new peer-reviewed study could play a pivotal role in that mission. Published in BMC Environmental Health and conducted by researchers at Harvard, UCLA, and Mount Sinai, the review examined 46 well-designed studies covering data from more than 100,000 mothers and children. Their focus was prenatal exposure to acetaminophen—the world’s most popular painkiller, sold under the brand name Tylenol—and its potential link to neurodevelopmental disorders like autism and ADHD.

The results were disturbing. According to the researchers, 27 studies found significant associations between prenatal acetaminophen exposure and disorders in children, with the strongest links pointing directly to autism spectrum disorder (ASD). In fact, the team reported “strong evidence” of a connection, noting that the higher the quality of the study, the more likely it was to show a positive association.

The science points to several pathways: acetaminophen freely crosses the placental barrier, reaching fetal circulation within an hour. Once inside, it is metabolized into toxic byproducts that can impact brain development. Researchers found evidence that the drug disrupts hormone processes, damages placental function, increases oxidative stress in the fetal brain, and interferes with key pathways tied to neural growth.

Dr. Didier Prada of Mount Sinai explained, “Our findings show that higher-quality studies are more likely to show a link between prenatal acetaminophen exposure and increased risks of autism and ADHD. Given the widespread use of this medication, even a small increase in risk could have major public health implications.”

This isn’t the first time concerns have been raised. Back in 2021, an international group of experts published a consensus warning in Nature Reviews Endocrinology, saying that growing evidence suggests prenatal acetaminophen exposure “might alter fetal development” and raise risks of autism, ADHD, language delays, and even lower IQ in children.

Yet despite mounting evidence, America’s medical establishment has continued to greenlight acetaminophen use during pregnancy. The FDA, along with most major medical groups, maintains that the drug is safe. Unsurprisingly, Tylenol’s manufacturer, Kenvue, pushed back hard against the new study, insisting there is “no causal link” and claiming the review doesn’t change its stance on the drug’s safety. The company even dismissed the findings as litigation-driven, since some of the authors have testified in lawsuits involving Tylenol use during pregnancy.

But Kennedy and his allies aren’t backing down. Under his leadership, HHS has pledged to “follow the science wherever it leads,” and this study adds new urgency to his autism investigation. With nearly 6 million more Americans reporting disabilities since 2021, the pressure to identify the causes and take action is greater than ever.

The reality is clear: America’s most widely used painkiller, trusted by millions of pregnant women, may be playing a hidden role in the autism epidemic. And while the corporate powers behind Tylenol dismiss the findings, parents and policymakers are starting to ask a different question—what if the warnings are true?

If even part of the evidence holds, the consequences could be staggering. A drug used casually by expectant mothers worldwide could be contributing to an autism crisis already at historic levels. And for families already struggling under the weight of these diagnoses, the idea that it might have been preventable only adds fuel to the outrage.

This battle isn’t over. As Kennedy promised, the truth about autism’s rise—and what’s driving it—is coming to light. And if Tylenol is part of the problem, the fallout will be enormous.